When a patient needs dialysis care in a skilled nursing facility, every minute matters. Case managers, discharge planners, patients, and families need timely answers so they can coordinate care, finalize placements, and avoid unnecessary delays.
To improve the referral experience, Dialyze Direct has implemented a new referral management platform and updated our internal intake workflows. The platform uses artificial intelligence to identify and extract key clinical information from referral packets, helping our intake coordinators review documentation more efficiently. [1]
The technology does not replace the expertise or judgment of our intake team. Instead, it helps organize important information so our coordinators can focus on evaluating each referral, communicating with partners, and moving the process forward.
It also provides the care team with a detailed summary of the patient’s clinical and care history. This information helps our clinicians better understand each patient’s needs and develop a more individualized, meaningful plan of care.
A Faster, More Transparent Referral Process
The updated system provides greater visibility into the status of each referral. This helps improve communication throughout the intake process and allows our team to respond more quickly when additional documentation or clarification is needed.
Since implementing the new platform and refining our intake workflows, our median referral approval turnaround time over the past 30 days has decreased to just 21 minutes! This is a significant improvement from our previous response goal of two hours.
Why Turnaround Time Matters
Faster referral decisions can make a meaningful difference for everyone involved in a patient’s transition of care.
For case managers and discharge planners, a prompt response helps reduce uncertainty and supports more efficient discharge planning. Skilled nursing facilities gain greater confidence that dialysis arrangements are being addressed. Most importantly, patients and their families receive answers sooner during what is often a stressful and complicated time.
While some referrals may require additional clinical information or coordination, our goal is to provide clear communication and a timely decision whenever possible.
By combining experienced intake professionals, improved workflows, and AI-assisted technology, Dialyze Direct is creating a smoother and more transparent referral experience for our skilled nursing facility partners and the patients they serve.
Ready to Get Started?
Refer a patient: Submit a referral through our secure online patient referral page.
Resources for case managers and providers: Learn more about our dialysis programs, referral process, and care options on our provider resources page.
Find a Dialyze Direct location: Search our network of skilled nursing facility partners using our location directory.
For additional information about kidney failure and dialysis treatment options, visit the National Institute of Diabetes and Digestive and Kidney Diseases.
[1] The platform supports HIPAA-compliant handling of protected health information through appropriate privacy and security safeguards.
If you or a loved one has been diagnosed with chronic kidney disease (CKD) or end-stage renal disease (ESRD), you may be wondering which type of dialysis is right for you.
Dialysis is a life-sustaining treatment that helps remove excess fluid, toxins, and waste products from the blood when the kidneys can no longer function properly. In the U.S., more than 808,000 people are living with end-stage kidney disease, also called ESRD, and about 68% receive dialysis, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Choosing between home dialysis and in-center dialysis is a major decision that impacts your health, lifestyle, and overall well-being.
Dialysis is a treatment that removes waste, toxins, and excess fluid from the blood when the kidneys are no longer able to do so effectively. There are two main types of dialysis, each with different methods of filtering the blood:
Many dialysis patients prefer home hemodialysis over in-center dialysis because it offers:
Choosing between home hemodialysis (HHD) and in-center dialysis impacts your lifestyle and health. While both provide life-sustaining treatment, home hemodialysis offers more flexibility, better health outcomes, and greater independence.
Most dialysis treatment options, including home and in-center dialysis, are covered by Medicare, Medicaid, and many private insurance plans.
Explore dialysis insurance coverage and what’s included
Understanding your insurance benefits can help you make a confident, informed decision about the best dialysis option for your needs.
Choosing a dialysis treatment is a significant decision. Your nephrologist or kidney care team can help assess your individual needs.
Whether you choose in-center hemodialysis, nocturnal home hemodialysis, or frequent daily home dialysis, the goal is to maintain the best possible health and quality of life.
If you’re considering home dialysis, talk to your doctor today to see if it’s the right option for you.
For some patients, home dialysis may offer more flexibility, more frequent treatment options, fewer post-treatment symptoms, and fewer diet or fluid restrictions. However, it is not the best choice for everyone. Your nephrologist can help determine whether home dialysis or in-center dialysis is safer and more appropriate for your condition.
Home dialysis requires training, storage space for supplies, careful infection prevention, and a comfort level with managing treatment at home. Some patients also need a care partner, depending on their treatment plan and medical needs.
Neither option is automatically better for everyone. Home hemodialysis uses a machine to filter the blood, while peritoneal dialysis uses the lining of the abdomen and dialysate fluid. The best choice depends on your health, lifestyle, support system, home environment, and your nephrologist’s recommendation.
Peritoneal dialysis may be less common because not every patient is a candidate, and some people are uncomfortable managing daily treatments at home. Other factors can include infection concerns, abdominal surgeries, hernias, limited home support, storage space, or a lack of early education about home dialysis options.
Dr. Allen Kaufman is the Chief Medical Officer and Senior VP for Clinical & Scientific Affairs at Dialyze Direct, with over four decades of experience in Nephrology. He began his career in 1980 and has held leadership roles including Chief of Nephrology & Hypertension at Beth Israel Medical Center (1998–2004), Chief of Dialysis at the Bronx VA Medical Center (1982–1990), and Chief of the Yorkville Dialysis Unit at Beth Israel and the Renal Research Institute (1990–2000). Dr. Kaufman has authored over 100 scientific publications and served as Principal or Co-Investigator on numerous NIH-funded research studies. A Fellow of the American College of Physicians, he is board-certified in Nephrology and Internal Medicine. He earned his medical degree from the University of Rochester and completed training at the Hospital of the University of Pennsylvania and Mount Sinai in New York. Dr. Kaufman is widely recognized with multiple “Best Doctor” and “Patients’ Choice” awards.
Did you know that diabetes is the leading cause of chronic kidney disease (CKD) and that anemia is a common complication of chronic kidney disease? According to the National Kidney Foundation (NKF), 1 in 3 adults with diabetes also has kidney disease.
At the same time, patients with chronic kidney disease experience reduced production of red blood cells, leading to anemia in CKD, a condition that causes extreme fatigue and worsens kidney function over time.
If you’re feeling tired, noticing unusual blood sugar spikes, or dealing with anemia, it’s crucial to understand how these issues are connected. Early detection and proper diabetes care can prevent kidney failure and improve your overall health.
Your kidneys perform several essential functions, including:
When blood sugar levels remain high (due to type 1 or type 2 diabetes), it damages the small blood vessels in the kidneys, contributing to diabetic kidney disease. This condition, called diabetic nephropathy, leads to kidney damage and reduces the kidneys’ ability to produce EPO (NIDDK).
Without enough EPO, your body doesn’t make sufficient red blood cells, leading to anemia in patients with diabetes, which worsens kidney health over time.
Diabetes is the #1 cause of chronic kidney disease and kidney failure in the U.S. (CDC). When blood glucose remains high for extended periods, it causes:
Over time, poorly controlled diabetes forces the kidneys to work harder, leading to progressive damage and, eventually, end-stage renal disease (ESRD). The National Kidney Foundation (NKF) reports that diabetes accounts for 50% of all kidney failure cases in the U.S.
Anemia in chronic kidney disease affects nearly 50% of CKD patients, especially in advanced stages (NIDDK). When the kidneys fail to produce enough erythropoietin (EPO), the bone marrow slows down red blood cell production.
This leads to:
Anemia in patients with type 2 diabetes and CKD can also increase the risk of heart disease, making diabetes care even more difficult.
Certain individuals face a higher risk of kidney disease and anemia due to diabetes:
Early detection through routine complete blood count (CBC) tests and kidney function tests can help slow the loss of kidney function.
If kidney disease progresses, options include:
Ignoring high blood sugar levels, anemia, and CKD symptoms can lead to kidney failure, requiring dialysis or a kidney transplant.
By taking control of your health today, you can prevent complications and improve your quality of life.
Kidney disease can affect how your body uses insulin, making blood sugar harder to control, especially in advanced stages or in people with diabetes.
Diabetes can lead to kidney damage, reducing erythropoietin production, which decreases red blood cell count and causes anemia over time.
Anemia commonly begins in stage 3 CKD and worsens in later stages due to reduced erythropoietin and iron deficiency.
Progression from stage 4 to stage 5 may take months to years, depending on health, blood pressure, diabetes control, and treatment adherence.
Early signs include fatigue, swelling in the ankles or face, and frequent or foamy urination, especially at night.
Information contained in this blog is for informational or educational purposes only and does not substitute professional medical advice or consultations with healthcare professionals. The content is not intended to be comprehensive or exhaustive, and it does not apply to any specific individual’s medical condition. Always refer to the personalized information given to you by your doctor, or contact us directly.
Dr. Allen Kaufman is the Chief Medical Officer and Senior VP for Clinical & Scientific Affairs at Dialyze Direct, with over four decades of experience in Nephrology. He began his career in 1980 and has held leadership roles including Chief of Nephrology & Hypertension at Beth Israel Medical Center (1998–2004), Chief of Dialysis at the Bronx VA Medical Center (1982–1990), and Chief of the Yorkville Dialysis Unit at Beth Israel and the Renal Research Institute (1990–2000). Dr. Kaufman has authored over 100 scientific publications and served as Principal or Co-Investigator on numerous NIH-funded research studies. A Fellow of the American College of Physicians, he is board-certified in Nephrology and Internal Medicine. He earned his medical degree from the University of Rochester and completed training at the Hospital of the University of Pennsylvania and Mount Sinai in New York. Dr. Kaufman is widely recognized with multiple “Best Doctor” and “Patients’ Choice” awards.
Imagine waking up one day to find that your kidneys are failing, your blood pressure is dangerously high, and your blood sugar is uncontrollable. This is a harsh reality for millions of people worldwide suffering from diabetes, hypertension, and chronic kidney disease (CKD). According to the Centers for Disease Control and Prevention (CDC), about 37 million American adults have CKD, and diabetes and hypertension are the leading causes. Understanding how these conditions are linked is crucial for the prevention, management, and reduction of the risk of kidney failure.
Diabetes is a chronic disease that affects the body’s ability to process blood sugar (glucose). There are two primary types:
The CDC states that over 90% of diabetes cases are Type 2 diabetes, which is strongly linked to obesity and lifestyle factors. A study published in the New England Journal of Medicine found that poorly controlled diabetes significantly increases the risk of kidney disease. High blood sugar levels over time can damage blood vessels, including those in the kidneys, leading to diabetic nephropathy, a leading cause of kidney disease worldwide.
Diabetic nephropathy, or diabetic kidney disease (DKD), affects about 40% of diabetic patients, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It begins with microalbuminuria, where small amounts of protein leak into the urine, and can progress to kidney failure if left unmanaged. Researchers emphasize that early detection of albuminuria and aggressive blood sugar control can slow kidney damage. Additionally, studies indicate that a hemoglobin A1C level below 7% significantly reduces the risk of diabetic kidney disease progression.
Hypertension, or high blood pressure, occurs when the force of blood against the artery walls is consistently too high. The American Heart Association estimates that nearly half of American adults have hypertension, and many are unaware of their condition.
Diabetes and hypertension often coexist, forming a vicious cycle that accelerates kidney damage. Several factors contribute to this connection:
According to the National Kidney Foundation, approximately 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure have CKD. A 2020 study in The Lancet Diabetes & Endocrinology found that diabetic patients with hypertension are at a 60% higher risk of developing kidney failure compared to those with normal blood pressure. When left untreated, CKD can progress to end-stage renal disease (ESRD), requiring dialysis or a kidney transplant.
The combination of high blood sugar and high blood pressure speeds up arteriosclerosis (hardening of the arteries), restricting blood flow to the kidneys. Additionally, insulin resistance, common in both diabetes and hypertension, has been found to promote fibrosis (scarring) in kidney tissues, worsening CKD progression. A 2023 meta-analysis in the American Journal of Nephrology reported that intensive blood pressure control (below 130/80 mmHg) can reduce CKD progression risk by 30%, emphasizing the importance of managing both conditions simultaneously.
As CKD progresses, it leads to severe complications, including:
Preventing and managing diabetes, hypertension, and kidney disease requires a multifaceted approach:
For patients with advanced CKD, treatment options include in-center dialysis or home dialysis solutions, which provide greater flexibility and comfort. Learn more about home dialysis options here.
The connection between diabetes, hypertension, and kidney disease is undeniable, but the good news is that early intervention can slow or prevent kidney damage. Proactive management of blood sugar and blood pressure is key.
To protect kidney function:
Your kidneys work tirelessly to filter waste and regulate essential functions, but they won’t sound an alarm until significant damage is done. Take charge of your health today, Because the best time to act is before the damage begins.
High blood sugar from diabetes damages kidney blood vessels over time, reducing filtration efficiency. This can lead to diabetic kidney disease, also called diabetic nephropathy, which is a leading cause of chronic kidney disease.
Kidney damage can develop after several years of uncontrolled diabetes. On average, significant effects appear 5–10 years after diagnosis, but strict blood sugar control can slow or prevent progression.
Symptoms may include fatigue, swelling in hands or feet, changes in urination, nausea, persistent itching, high blood pressure, and loss of appetite. Early detection through testing is critical to prevent complications.
Kidney damage from type 2 diabetes is generally not reversible. However, progression can be slowed or managed with strict blood sugar control, blood pressure management, medications, and lifestyle changes.
Early signs include changes in urination (frequency, foamy or bloody urine), swelling in the hands, feet, or face, and persistent fatigue caused by toxin buildup and reduced kidney function.
Yes. Progression can be slowed by controlling blood sugar and blood pressure, following a kidney-friendly diet, avoiding kidney-harming medications, and regular monitoring under a healthcare provider’s guidance.
Information contained in this blog is for informational or educational purposes only and does not substitute professional medical advice or consultations with healthcare professionals. The content is not meant to be complete or exhaustive or to apply to any specific individual’s medical condition. Always refer to the personalized information given to you by your doctor or contact us directly.
Dr. Allen Kaufman is the Chief Medical Officer and Senior VP for Clinical & Scientific Affairs at Dialyze Direct, with over four decades of experience in Nephrology. He began his career in 1980 and has held leadership roles including Chief of Nephrology & Hypertension at Beth Israel Medical Center (1998–2004), Chief of Dialysis at the Bronx VA Medical Center (1982–1990), and Chief of the Yorkville Dialysis Unit at Beth Israel and the Renal Research Institute (1990–2000). Dr. Kaufman has authored over 100 scientific publications and served as Principal or Co-Investigator on numerous NIH-funded research studies. A Fellow of the American College of Physicians, he is board-certified in Nephrology and Internal Medicine. He earned his medical degree from the University of Rochester and completed training at the Hospital of the University of Pennsylvania and Mount Sinai in New York. Dr. Kaufman is widely recognized with multiple “Best Doctor” and “Patients’ Choice” awards.
Did you know that high blood pressure (hypertension) is the second leading cause of kidney failure in the United States? Many people don’t realize that their high blood pressure is slowly damaging their kidneys, until it’s too late. At the same time, kidney disease can worsen blood pressure, creating a dangerous cycle that can lead to chronic kidney disease (CKD) and even kidney failure.
According to the Centers for Disease Control and Prevention (CDC), about 37 million adults in the U.S. have CKD, and high blood pressure is responsible for nearly 1 in 4 cases of kidney failure. Additionally, nearly half of U.S. adults have hypertension, and many are unaware of their condition. Understanding how these two conditions affect each other is critical for prevention, early detection, and effective treatment.
The kidneys rely on a vast network of blood vessels in the kidneys to filter waste and remove extra fluid from your body. Uncontrolled high blood pressure exerts excessive force on blood vessel walls, causing them to constrict and narrow, reducing blood flow to your kidneys. Over time, this leads to kidney disease caused by high blood pressure. Studies show that people with hypertension are five times more likely to develop CKD compared to those with normal blood pressure.
When blood flow is reduced, the kidneys cannot properly filter toxins and excess fluid, leading to fluid retention. This further raises blood pressure, creating a vicious cycle of damage that can lead to advanced kidney disease or even kidney failure in the United States. According to the National Kidney Foundation, a decline in kidney function is measured by the glomerular filtration rate (GFR), with a GFR below 60 mL/min indicating CKD. If GFR drops below 15, dialysis or a kidney transplant is required.
High blood pressure damages the tiny blood vessels in the kidneys, including the glomeruli, which are responsible for filtering waste. As a result, protein that should remain in the bloodstream leaks into urine, a condition known as proteinuria. Protein in the urine is an early sign of kidney damage and a major risk factor for CKD progression.
When the kidneys fail to remove excess fluid, it increases blood volume, leading to higher blood pressure levels. This is why people with kidney disease often experience swelling in the legs and face. According to research, even a 5% increase in fluid retention can raise systolic pressure by 10 mmHg.
The kidneys help regulate blood pressure by producing hormones like renin, which controls blood volume and sodium levels. However, kidney disease disrupts these hormones, making it even harder to control your blood pressure. A 2023 study published in the Journal of Hypertension found that renin-angiotensin system (RAS) dysfunction is a primary contributor to hypertension in CKD patients.
Both high blood pressure and kidney disease put extra strain on the heart and arteries that carry blood. People with CKD are twice as likely to develop heart disease, and high cholesterol further increases this risk. The American Heart Association reports that 60% of CKD patients also suffer from cardiovascular disease.
Early kidney disease and high blood pressure often have no symptoms. However, as they progress, signs may include:
If you experience these symptoms, a blood test and urine test can help detect kidney disease and assess blood pressure levels. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), early CKD detection through estimated GFR (eGFR) tests can delay kidney failure by up to 50%.
If you have high blood pressure or kidney disease, regular checkups are essential. You should see a doctor if:
For those with advanced kidney disease, exploring treatment options such as home dialysis can provide more flexibility and a better quality of life while managing kidney health.
By understanding this connection and taking proactive steps, you can safeguard your kidneys, lower your blood pressure, and improve long-term health outcomes.
If CKD progresses, treatment may involve:
Learn what your insurance covers for dialysis and kidney-related treatments here
Hypertension and kidney disease don’t just affect the kidneys, they impact your heart, your energy, and your overall quality of life. The good news? With early detection, lifestyle changes, and proper medical care, you can delay or prevent kidney failure.
Understanding the relationship between blood pressure and kidney function can help you make informed decisions to protect your health. Don’t wait for symptoms, start monitoring your blood pressure, get tested, and talk to your doctor today.
Because once kidney damage starts, it’s hard to undo. But you can stop it from getting worse.
Yes, uncontrolled hypertension is a leading cause of kidney disease, even without diabetes.
It can’t be reversed, but slowing its progression is possible through good blood pressure control.
Daily home monitoring and regular check-ins with your doctor are recommended.
Eat foods rich in potassium (unless restricted), whole grains, leafy greens, berries, and low-sodium meals.
Untreated, they can lead to heart failure, stroke, and kidney failure requiring dialysis or a transplant.
Dr. Allen Kaufman is the Chief Medical Officer and Senior VP for Clinical & Scientific Affairs at Dialyze Direct, with over four decades of experience in Nephrology. He began his career in 1980 and has held leadership roles including Chief of Nephrology & Hypertension at Beth Israel Medical Center (1998–2004), Chief of Dialysis at the Bronx VA Medical Center (1982–1990), and Chief of the Yorkville Dialysis Unit at Beth Israel and the Renal Research Institute (1990–2000). Dr. Kaufman has authored over 100 scientific publications and served as Principal or Co-Investigator on numerous NIH-funded research studies. A Fellow of the American College of Physicians, he is board-certified in Nephrology and Internal Medicine. He earned his medical degree from the University of Rochester and completed training at the Hospital of the University of Pennsylvania and Mount Sinai in New York. Dr. Kaufman is widely recognized with multiple “Best Doctor” and “Patients’ Choice” awards.